• About Us
  • Privacy Policy
  • Contact Us
Subscribe
BitcoinCryptos - News About Bitcoin & Cryptos
  • Home
  • Bitcoin
  • Ethereum
  • Dogecoin
  • Litecoin
  • Cryptocurrency
  • Blockchain
  • Regulation
  • Market
  • Prices
No Result
View All Result
  • Home
  • Bitcoin
  • Ethereum
  • Dogecoin
  • Litecoin
  • Cryptocurrency
  • Blockchain
  • Regulation
  • Market
  • Prices
No Result
View All Result
BitcoinCryptos
No Result
View All Result
Home Cryptocurrency

Merck (MRK) Stock Up 11% after Announcement of Positive COVID-19 Pill Trial Result

October 1, 2021
in Cryptocurrency
0
Merck (MRK) Stock Up 11% after Announcement of Positive COVID-19 Pill Trial Result
Share on FacebookShare on Twitter


The company plans to apply for Emergency Use Authorization (EUA) with the US FDA based on the findings of the trial and there are also plans to submit marketing applications to other regulatory bodies worldwide.

The shares of American multinational pharmaceutical company Merck & Co., Inc (NYSE: MRK) is currently trading with good gains of 11%  following the announcement from the company that the oral antiviral drug it developed as a treatment for COVID-19 with partner Ridgeback Biotherapeutics reduced the risk of hospitalization or death in at-risk adult patients with mild-to-moderate COVID by about 50% in an interim analysis of data from a Phase 3 trial. The company’s stock was changing hands at $83.66 at the time of writing.

The Merck trial featured 775 patients around the world, with the enrolled participants taking the COVID-19 medicine named molnupiravir, every 12 hours for five days. The company’s trial showed that 7.3% of those given molnupiravir were either hospitalized or had died by 29 days after treatment, compared with 14.1% of placebo patients. There were no deaths in the molnupiravir group, but there were eight deaths of placebo patients.

“With the virus continuing to circulate widely, and because therapeutic options currently available are infused and/or require access to a healthcare facility, antiviral treatments that can be taken at home to keep people with COVID-19 out of the hospital are critically needed,” said Wendy Holman, chief executive officer of Ridgeback Biotherapeutics. “We are very encouraged by the results from the interim analysis and hope molnupiravir, if authorized for use, can make a profound impact in controlling the pandemic. Our partnership with Merck is critical to ensuring rapid global access if this medicine is approved, and we appreciate the collaborative effort to reach this important stage of development.”

The duo of Merck and Ridgeback pointed out that the “incidence of any adverse event was comparable in the molnupiravir and placebo groups coming in at 35% and 40%, respectively.”

Merck COVID-19 Drug: Plans to Promote Accessibility

While millions of people around the world have either taken one or two shots of the COVID-19 vaccines produced by other competing pharmaceutical firms, Merck’s product is set to gain a competitive advantage with its oral administration style. As such, the company said it plans to promote accessibility to the medicine hinged on predefined partnerships with the US Government and other nations.

While the firm also confirmed it is pushing for new agreements with other countries, it said it will license their medicine to generic drug manufacturers that can help scale production and push the drugs to areas where they are most needed.

“As part of its commitment to widespread global access, Merck previously announced that the company has entered into non-exclusive voluntary licensing agreements for molnupiravir with established generic manufacturers to accelerate availability of molnupiravir in more than 100 low- and middle-income countries (LMICs),” Merck said in a statement.

The company plans to apply for Emergency Use Authorization (EUA) with the US FDA based on the findings of the trial and there are also plans to submit marketing applications to other regulatory bodies worldwide.

next Business News, Market News, News, Stocks

Benjamin Godfrey

Benjamin Godfrey is a blockchain enthusiast and journalists who relish writing about the real life applications of blockchain technology and innovations to drive general acceptance and worldwide integration of the emerging technology. His desires to educate people about cryptocurrencies inspires his contributions to renowned blockchain based media and sites. Benjamin Godfrey is a lover of sports and agriculture.

Thank you!

You have successfully joined our subscriber list.



Source link

Related articles

USELESS Token Soars 2,000% in June as Bonk Guy Shills New Memecoin to $200M Market Cap

USELESS Token Soars 2,000% in June as Bonk Guy Shills New Memecoin to $200M Market Cap

July 2, 2025
SEC Approves Grayscale Multi-Asset Crypto ETF Including XRP, Solana, Cardano

SEC Approves Grayscale Multi-Asset Crypto ETF Including XRP, Solana, Cardano

July 2, 2025
Tags: AnnouncementCOVID19MerckMRKPillpositiveResultStocktrial
Share76Tweet47

Related Posts

USELESS Token Soars 2,000% in June as Bonk Guy Shills New Memecoin to $200M Market Cap

USELESS Token Soars 2,000% in June as Bonk Guy Shills New Memecoin to $200M Market Cap

July 2, 2025
0

Key NotesBonk Guy's June 9 endorsement triggered USELESS token's meteoric rise from $10M to $217M peak valuation within weeks.The memecoin...

SEC Approves Grayscale Multi-Asset Crypto ETF Including XRP, Solana, Cardano

SEC Approves Grayscale Multi-Asset Crypto ETF Including XRP, Solana, Cardano

July 2, 2025
0

Key NotesFirst US multi-crypto ETF approved following CoinDesk 5 Index with Bitcoin dominating at 80.20% allocation.XRP, Solana, and Cardano gain...

Dogecoin Price Prediction: $60M Shorts Threaten DOGE Recovery as Falling Wedge Targets 41% Rally

Dogecoin Price Prediction: $60M Shorts Threaten DOGE Recovery as Falling Wedge Targets 41% Rally

July 1, 2025
0

Key NotesMarket rotation drives DOGE decline as traders chase 2000%+ gains in low-cap memes like $USELESS over established tokens.Short traders...

Pi Coin May Drop to $0.4 After Weak Pi2Day AI Reveal

Pi Coin May Drop to $0.4 After Weak Pi2Day AI Reveal

July 1, 2025
0

Key NotesPi Coin selling pressure is compounded by the upcoming unlock of 318 million Pi tokens over the next 30...

xStocks Lands on Solana, Bybit

xStocks Lands on Solana, Bybit

July 1, 2025
0

Key NotesBacked launched xStocks, bringing over 60 tokenized equities to Bybit, Kraken, and the Solana blockchain.Kraken and Bybit have integrated...

Load More

Leave a Reply

Your email address will not be published. Required fields are marked *

Corporations Scooped up More BTC Than ETFs For Third Straight Quarter

Corporations Scooped up More BTC Than ETFs For Third Straight Quarter

July 2, 2025
0

Corporate treasuries have surpassed ETFs for Bitcoin purchases for a third consecutive quarter. Around 131,000 BTC was accumulated by public...

Figma IPO Filing Reveals $70M Bitcoin ETF Holdings

Figma IPO Filing Reveals $70M Bitcoin ETF Holdings

July 2, 2025
0

Design software company Figma revealed in a regulatory filing that it owns nearly $70 million worth of shares in Bitcoin...

Crypto Sentiment Remains Strong Despite BTC Price Drop

Crypto Sentiment Remains Strong Despite BTC Price Drop

July 2, 2025
0

Crypto market sentiment has held steady despite Bitcoin tumbling almost 2% over the past day to change hands close to...

Arizona governor rejects Bitcoin reserve bill HB 2324, says it hurts asset forfeiture cooperation

Arizona governor rejects Bitcoin reserve bill HB 2324, says it hurts asset forfeiture cooperation

July 2, 2025
0

Key Takeaways Arizona Governor Katie Hobbs vetoed HB 2324, which proposed a state-managed Bitcoin and digital asset reserve fund. The...

Crypto Sentiment Remains Strong Despite BTC Price Drop

Crypto Sentiment Remains Strong Despite BTC Price Drop

July 2, 2025
0

Crypto market sentiment has held steady despite Bitcoin tumbling almost 2% over the past day to change hands close to...

We have all the news related to the crypto market and we make sure to bring and publish all the updates as fast as we can.

Categories

  • Bitcoin
  • Blockchain
  • Cryptocurrency
  • Dogecoin
  • Ethereum
  • Litecoin
  • Market
  • Regulation

Archives

  • 2025
  • 2024
  • 2023
  • 2022
  • 2021

Newsletter

    • About Us
    • Privacy Policy
    • Contact Us

    © 2021 bitcoincryptos.com

    Please enter CoinGecko Free Api Key to get this plugin works.
    No Result
    View All Result
    • Home
    • Bitcoin
    • Ethereum
    • Dogecoin
    • Litecoin
    • Cryptocurrency
    • Blockchain
    • Regulation
    • Market
    • Prices

    © 2018 JNews by Jegtheme.